ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA approves Kyowa Kirin’s Nourianz drug for Parkinson’s disease
September 03, 2019The US Food and Drug Administration (FDA) has approved Japanese company Kyowa Kirin’s drug Nourianz (istradefylline) as an add-on to the existing drug levodopa/carbidopa to treat adults... -
Nourianz Approved to Treat 'Off' Episodes in Parkinson Disease
August 29, 2019Nourianz (istradefylline) tablets have been approved as an add-on treatment to levodopa/carbidopa for adults with Parkinson disease experiencing "off" episodes... -
FDA Approves Nourianz (istradefylline) as an Add-On Drug to Treat Off Episodes in Adults with Parkinson’s Disease
August 28, 2019The U.S. Food and Drug Administration today approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing "off" episodes.
Pharma Sources Insight January 2025
